Gemin2 plays an important role in stabilizing the survival of motor neuron complex.

J Biol Chem

Genome Exploration Research Group, RIKEN Genomic Sciences Center, RIKEN Yokohama Institute, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan.

Published: April 2007

The survival of motor neuron (SMN) protein, responsible for the neurodegenerative disease spinal muscular atrophy (SMA), oligomerizes and forms a stable complex with seven other major components, the Gemin proteins. Besides the SMN protein, Gemin2 is a core protein that is essential for the formation of the SMN complex, although the mechanism by which it drives formation is unclear. We have found a novel interaction, a Gemin2 self-association, using the mammalian two-hybrid system and the in vitro pull-down assays. Using in vitro dissociation assays, we also found that the self-interaction of the amino-terminal SMN protein, which was confirmed in this study, became stable in the presence of Gemin2. In addition, Gemin2 knockdown using small interference RNA treatment revealed a drastic decrease in SMN oligomer formation and in the assembly activity of spliceosomal small nuclear ribonucleoprotein (snRNP). Taken together, these results indicate that Gemin2 plays an important role in snRNP assembly through the stabilization of the SMN oligomer/complex via novel self-interaction. Applying the results/techniques to amino-terminal SMN missense mutants that were recently identified from SMA patients, we successfully showed that amino-terminal self-association, Gemin2 binding, the stabilization effect of Gemin2, and snRNP assembly activity were all lowered in the mutant SMN(D44V), suggesting that instability of the amino-terminal SMN self-association may cause SMA in patients carrying this allele.

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M609297200DOI Listing

Publication Analysis

Top Keywords

smn protein
12
amino-terminal smn
12
gemin2
8
gemin2 plays
8
plays role
8
survival motor
8
motor neuron
8
smn
8
assembly activity
8
snrnp assembly
8

Similar Publications

The effect of silymarin on diabetes mellitus-induced male rats reproductive impairment: Evidences for role of heat shock proteins 70 and 90.

Pol J Vet Sci

December 2024

Department of Basic sciences, Faculty of Veterinary Medicine, Tabriz medical sciences branch, Islamic Azad University, 5159115705, Tabriz, Iran.

Male fertility is adversely influenced by diabetes. The beneficial effects of antioxidant bioflavonoids in improving fertility have been reported. This study was conducted to evaluate the effects of silymarin on diabetes mellitus-induced male reproductive impairment in rats by investigating its role in Hsp70 and Hsp90 expression.

View Article and Find Full Text PDF

The development of ground-breaking Survival Motor Neuron (SMN) replacement strategies has revolutionized the field of Spinal Muscular Atrophy (SMA) research. However, the limitations of these therapies have now become evident, highlighting the need for the development of complementary targets beyond SMN replacement. To address these challenges, here we explored, in in vitro and in vivo disease models, Stathmin-2 (STMN2), a neuronal microtubule regulator implicated in neurodegenerative diseases like Amyotrophic Lateral Sclerosis (ALS), as a novel SMN-independent target for SMA therapy.

View Article and Find Full Text PDF

Advances in Disease-Modifying Therapeutics for Chronic Neuromuscular Disorders.

Semin Respir Crit Care Med

December 2024

Department of Neurology and Rehabilitation Medicine, University of Cincinnati, Cincinnati, Ohio.

Article Synopsis
  • Neuromuscular disorders significantly impact respiratory function by affecting the muscles involved in breathing, leading to high rates of morbidity and mortality, but new therapies have emerged to help combat these issues.
  • Recent FDA-approved treatments for Myasthenia Gravis (MG) and Spinal Muscular Atrophy (SMA) show promising results; therapies targeting the complement system or enhancing SMN protein production improve respiratory function and overall clinical outcomes.
  • While advancements in treating Late-Onset Pompe Disease (LOPD) and Amyotrophic Lateral Sclerosis (ALS) have been made, the latter still presents challenges, with new drugs only managing to slow progression rather than halt it.
View Article and Find Full Text PDF
Article Synopsis
  • The lab has been studying RNA-binding proteins (RBPs) and their complexes (RNPs) since the 1980s, focusing on their roles in regulating gene expression after transcription.* -
  • Research uncovered links between RBPs, specific diseases like fragile X syndrome and spinal muscular atrophy, highlighting the connection between RNA biology and health conditions.* -
  • The findings show that the diverse range of RNAs and RBPs can lead to increased complexity and potential disorders, suggesting a promising area for future research and discoveries in RNA science.*
View Article and Find Full Text PDF

Spinal muscular atrophy (SMA) is caused by low levels of the survival motor neuron (SMN) protein. Even though SMN is ubiquitously expressed, the disease selectively affects motor neurons, leading to progressive muscle weakness. Even among motor neurons, certain motor units appear more clinically resistant to SMA.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!